AstraZeneca antibody drug important as preventative COVID-19 therapy – exec

By Reuters

“I don't think treatment is where we are going to be competing,” Mene Pangalos, executive vice president for bio-pharmaceuticals R&D at AstraZeneca, said during a media briefing. Pangalos added that the Anglo-Swedish drugmaker would use its existing supply chains to manufacture the antibodies and would have supplies online by the end of the year and “ready to go” by the time of approvals.

…read more

Via:: Sports Headlines

      

Get 20% off hat purchases for ONLY $5! Join our LIDS Club @ lids.com.
%d bloggers like this: